Young BioPharma — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Young BioPharma is an early-stage biotech leveraging natural product chemistry to discover new drugs for pain and oncology. The company boasts a seasoned leadership team with deep experience in drug development, including key contributors to the approved anticancer drug Halaven. With a proprietary library of over 10,000 natural products and multiple in-house assays, Young BioPharma is building a preclinical pipeline but operates as a private, pre-revenue entity facing significant development and funding risks inherent to the sector.

PainOncology

Technology Platform

Proprietary natural product-based drug discovery platform featuring a library of over 10,000 screened natural products and more than 10 in-house developed biological assays for high-throughput screening in pain and oncology targets.

Opportunities

The large and growing markets for non-opioid pain therapies and novel oncology drugs present significant commercial opportunities.

Successfully leveraging natural products could yield novel mechanisms of action with strong intellectual property, addressing high unmet medical needs.

Risk Factors

High scientific risk due to the challenges of natural product drug discovery and high preclinical attrition rates.

Significant financial risk as a private, pre-revenue company dependent on external funding.

Intense competition in both target therapeutic areas from well-resourced entities.

Competitive Landscape

The non-opioid pain and oncology drug development spaces are highly competitive, featuring large pharmaceutical companies, established biotechs, and numerous startups exploring various modalities (e.g., biologics, gene therapy, small molecules). Young BioPharma competes by focusing on natural product-derived small molecules, a niche that requires specialized expertise but offers potential for novel chemistry.

More companies in Small Molecule Drugs →More companies in United States →